Venture Partnerships & Investments

Our Investment Focus & Philosophy

Our goals are to recognize potential, get involved early, limit threats and accept reasonable risks. The many assets Zühlke Ventures provide include sound financing, a wealth of management and technology experience, and our strong network.

Our investment philosophy focuses on:

  • Focus: Focus exclusively on early-stage investments in the HealthTech sector.
  • Duration: 5 - 8 years
  • Geography: Main activity in Switzerland and Europe, complemented by interests in the US.
  • Scale: Zühlke Ventures hold a minority stake, with initial investments of CHF 150k – 250k per start-up.
  • Cooperations: Proactive, cooperative partnership gives start-up management access to Zühlke Group know-how.

Our Companies

Our Exits

  • Swisstom

    Acquired by Sentec in 2018

    Swisstom Partner
  • Message Automation

    Acquired by Broadridge in 2017

    Message Automation Partner
  • Lunaphore

    Acquired by Bio-Techne in 2023

    Logo of Lunaphore

Interested in finding out more? Get in touch!

  • Patrick Griss

    CEO Ventures & Partner

  • Stephan Wehrli


Let us get in touch with you